Zhejiang Taimei Medical Technology Co., Ltd. (HKG:2576)
Hong Kong
· Delayed Price · Currency is HKD 3.780
+0.120 (3.28%)
May 9, 2025, 4:08 PM HKT
HKG:2576 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 551.16 | 573.14 | 549.22 | 466.18 | 302.95 | Upgrade
|
| Revenue Growth (YoY) | -3.84% | 4.36% | 17.81% | 53.88% | 61.68% | Upgrade
|
| Cost of Revenue | 326.21 | 394.14 | 363.81 | 301.85 | 178.65 | Upgrade
|
| Gross Profit | 224.94 | 179 | 185.4 | 164.33 | 124.31 | Upgrade
|
| Selling, General & Admin | 408.99 | 419.12 | 473.79 | 446.23 | 516.06 | Upgrade
|
| Research & Development | 87.05 | 169.19 | 208.18 | 190.84 | 108.99 | Upgrade
|
| Other Operating Expenses | -9.64 | -16.24 | -15.69 | -13.56 | -6.87 | Upgrade
|
| Operating Expenses | 489.99 | 580.4 | 670.84 | 626.92 | 619.63 | Upgrade
|
| Operating Income | -265.05 | -401.4 | -485.44 | -462.59 | -495.32 | Upgrade
|
| Interest Expense | -0.73 | -1.43 | -2.68 | -2.71 | -1.07 | Upgrade
|
| Interest & Investment Income | 37.05 | 41.65 | 22.88 | 28.74 | 24.33 | Upgrade
|
| Currency Exchange Gain (Loss) | 17.48 | 8.65 | 54.03 | -7.96 | -22.85 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | 1.27 | -0.82 | -0.46 | Upgrade
|
| EBT Excluding Unusual Items | -211.25 | -352.53 | -409.94 | -445.33 | -495.37 | Upgrade
|
| Impairment of Goodwill | -9.8 | -8.37 | -22.38 | -54.09 | -29.48 | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.76 | 5.84 | 9.79 | 19.8 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.17 | - | -0.47 | 0.02 | 0.01 | Upgrade
|
| Asset Writedown | - | -1.2 | - | - | -0 | Upgrade
|
| Other Unusual Items | 0.04 | -0.11 | 0.42 | - | - | Upgrade
|
| Pretax Income | -217.41 | -356.36 | -422.58 | -479.61 | -524.85 | Upgrade
|
| Income Tax Expense | - | 0.02 | - | 0.01 | -0.47 | Upgrade
|
| Earnings From Continuing Operations | -217.41 | -356.38 | -422.58 | -479.61 | -524.38 | Upgrade
|
| Minority Interest in Earnings | 2.8 | 9.6 | 9.67 | - | - | Upgrade
|
| Net Income | -214.61 | -346.78 | -412.91 | -479.61 | -524.38 | Upgrade
|
| Net Income to Common | -214.61 | -346.78 | -412.91 | -479.61 | -524.38 | Upgrade
|
| Shares Outstanding (Basic) | 544 | 538 | 538 | 538 | 467 | Upgrade
|
| Shares Outstanding (Diluted) | 544 | 538 | 538 | 538 | 467 | Upgrade
|
| Shares Change (YoY) | 1.10% | - | - | 15.22% | - | Upgrade
|
| EPS (Basic) | -0.39 | -0.64 | -0.77 | -0.89 | -1.12 | Upgrade
|
| EPS (Diluted) | -0.39 | -0.64 | -0.77 | -0.89 | -1.12 | Upgrade
|
| Free Cash Flow | -207.3 | -355.52 | -353.62 | -247.63 | -109.62 | Upgrade
|
| Free Cash Flow Per Share | -0.38 | -0.66 | -0.66 | -0.46 | -0.23 | Upgrade
|
| Gross Margin | 40.81% | 31.23% | 33.76% | 35.25% | 41.03% | Upgrade
|
| Operating Margin | -48.09% | -70.04% | -88.39% | -99.23% | -163.50% | Upgrade
|
| Profit Margin | -38.94% | -60.50% | -75.18% | -102.88% | -173.09% | Upgrade
|
| Free Cash Flow Margin | -37.61% | -62.03% | -64.39% | -53.12% | -36.19% | Upgrade
|
| EBITDA | -248.66 | -378.66 | -463.41 | -451.58 | -493.89 | Upgrade
|
| EBITDA Margin | -45.12% | -66.07% | -84.38% | -96.87% | -163.02% | Upgrade
|
| D&A For EBITDA | 16.39 | 22.74 | 22.03 | 11 | 1.43 | Upgrade
|
| EBIT | -265.05 | -401.4 | -485.44 | -462.59 | -495.32 | Upgrade
|
| EBIT Margin | -48.09% | -70.04% | -88.39% | -99.23% | -163.50% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.